Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

iwAL 2018 Session IV

 

Treatment strategies in ALL

Session IV of iwAL 2018 Charles Mullighan, MBBS, MD, and Daniel DeAngelo, MD, PhD, discuss recent treatment advances in various ALL populations, including children, young adolescents and adults.

Presentations
Treatment Advances in ALL for Children & Young Adolescents
Charles Mullighan, MBBS, MD
St. Jude Children’s Research Hospital, Memphis, TN
10 February, 2018

Charles Mullighan, MBBS, MD, St. Jude Children’s Research Hospital, Memphis, TN, talks about advances in the treatment of ALL in children and young adolescents.

Treatment Advances in ALL for Adults
Daniel DeAngelo, MD, PhD
Dana-Farber Cancer Institute, Boston, MA
10 February, 2018

Daniel DeAngelo, MD, PhD, from the Dana-Farber Cancer Institute, Boston, MA, presents on treatment advances in adult ALL.

Previous session View all sessions Next session
The content of VJHemOnc is intended for healthcare professionals